Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies. [electronic resource]
Producer: 20140708Description: 171 p. digitalISSN:- 1476-511X
- Curcumin -- therapeutic use
- Fatty Acid Synthase, Type I -- genetics
- Fatty Liver -- drug therapy
- Fibric Acids -- therapeutic use
- Forkhead Box Protein O1
- Forkhead Transcription Factors -- genetics
- Gene Expression Regulation
- Humans
- Lipid Metabolism -- drug effects
- Liver -- drug effects
- Mitochondria -- drug effects
- Non-alcoholic Fatty Liver Disease
- PPAR gamma -- genetics
- Peroxisomes -- drug effects
- Pregnane X Receptor
- Protective Agents -- therapeutic use
- Receptors, Cytoplasmic and Nuclear -- genetics
- Receptors, Steroid -- genetics
- Thiazolidinediones -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.